Related Experiment Videos
Management of status epilepticus
1Division of Emergency Medicine, University of Florida Health Science Center/Jacksonville.
Emergency Medicine Clinics of North America
|November 1, 1994
Summary
Status epilepticus management has improved, reducing patient harm. Prompt treatment and addressing underlying causes are crucial for better outcomes in seizure emergencies.
Area of Science:
- Neurology
- Emergency Medicine
Background:
- Status epilepticus (SE) management has seen significant advances, decreasing morbidity and mortality over the past two decades.
- Any seizure type can evolve into SE, necessitating prompt recognition and intervention.
Purpose of the Study:
- To review the current understanding of status epilepticus pathophysiology, evaluation, and management.
- To emphasize the importance of identifying and treating underlying causes, especially in refractory cases.
Main Methods:
- Review of current literature on status epilepticus management.
- Discussion of established and emerging treatment modalities.
Main Results:
- Advances in SE care have led to reduced patient morbidity and mortality.
- Identifying and managing underlying causes is critical for treatment success, particularly in severe cases.
- Standard pharmacologic agents include benzodiazepines, phenytoin, and phenobarbital.
Conclusions:
- Timely, organized care significantly impacts patient outcomes in status epilepticus.
- Pentobarbital anesthesia is the recommended treatment for refractory SE when first- and second-line agents fail.